Izmo Limited and it's three business divisions- 🧵

1. Izmo Cars
2. Izmo Studio
3. Frog Data 2/n

Segmental Revenue-

H1FY24 Revenue Breakup:

1. Izmo Cars- 34%
2. Izmo Studio- 42%
3. Frog Data- 24%

Let's delve into a thread about Essen Speciality Films Limited (ESFL).

In this thread, we'll explore their diverse product range, market position, financial stability, and key strengths. Here we go! 🌐✨ 2/n

📍Essen Speciality Films, established in 2002, crafts a diverse range of specialty products, including desk mats, foam disposables, and artificial plants. Catering to global furnishing giants, it operates within a niche segment.

[Proxy to IKEA?😀]

Sharekhan on #LaurusLabs

Thread🧵

Concerns Overdone; Growth prospects intact⚡️

Target Price: 800

Basis sturdy growth prospects and capacity expansion plans, Laurus has targeted for a $1bn revenues by FY23

Long term driver in place

Q2FY22 earnings trajectory to be intact👇🏻 (2/n)

During Q1FY22 Laurus has commissioned its 1 bn tablets capacity in the FD (Finished Dosages) segment and the same would add to the Q2FY22 performance.

Also new client additions, growth from existing customers would drive the synthesis segment sales.

#GNFC
A brief thread on Gujarat Narmada Valley Fertilizers & Chemicals

Incorporated in 1976 by Govt of Gujarat, manufacturer & trader of fertilizers, industrial chemicals covering a wide range of products

Largest Manufacturer of Toluene Di-Isocyanate, Aniline, Acetic Acid
(1/n) #GNFC (2/n)

GNFC is the sole Manufacturer of TDI in India with a market share of 70%; rest 30% is imported.

Key Financial Ratios:

Market Cap: 6,981 Cr
P/S: 1.20
D/E: 0
P/E: 7.46
ROCE: 15.8%
Promoter + FII + DII: 63.17%

FY21 Sales: 5,129 Cr
EBITDA: 1,003 Cr
OPM: 20%

#JubilantIngrevia - Thread ⚡️

Global Integrated Life Science Products and Innovative Solutions Provider

Market Cap- 12,153Cr
FY21 Sales- 3,491Cr
Q1FY22 Sales- 1,145 Cr

~1,400 Total customers
3 Segments and 165+Products
60+ New products in the pipeline over the next 3-4 years (2/n)
Ingrevia has strong presence in diverse sectors like Pharmaceuticals, Life Science Ingredients, Contract Research & Development Services, and Therapeutics, Performance Polymers, Food Service, Auto, Consulting in Aerospace

FY21- EBITDA-627Cr(17.9%)
ROCE-20.2%

900Cr CAPEX

#Syngene - Thread⚡️

An integrated service provider offering end-to-end drug discovery, development, and manufacturing services on a single platform.

25+ years of unparalleled experience

@unseenvalue @AvadhMaheshwar2 @caniravkaria @Jitendra_stock @saketreddy @itsTarH (2/n)
Syngene, a subsidiary of Biocon Ltd, was established in 1993 as India’s first Contract Research Organization.

CRO is a company that provides support to the pharma industry in the form of research services outsourced on a contract basis. CROs are designed to reduce costs.

HFCL - Bubble or 5G Opportunity - Thread⚡️

Leading manufacturer of optical fiber cables, optical transport, power electronics, and broadband equipment for the telecommunication industry

@Atulsingh_asan @caniravkaria @AvadhMaheshwar2  @saketreddy @Jitendra_stock  @AnishA_Moonka #HFCL (2/n)

Wide Industries Served: Telecom, Defence, Railways, Security and Surveillance

8 Year Revenue CAGR: 25%

8 Year PAT CAGR: 20%

FY21 ROCE: 19.80%

D/E: 0.48x

R&D facilities at Bengaluru and Gurugram

Key Customers: Jio, BSNL, Tata, Airtel

Exporting to 30+ countries

Deepak Fertilisers - Thread⚡️

Established in 1979, Deepak Fertilisers And Petrochemicals Corporation Limited(DFPCL) is one of India’s leading producers of fertilisers and industrial chemicals.

@caniravkaria @saketreddy @nakulvibhor @Jitendra_stock @AvadhMaheshwar2 @TSG_Capital (2/n)

Set up by Chimanlal K Mehta [Founder of Deepak Nitrite] as an ammonia manufacturer, the Rs 4,000 cr DFPCL is today run by his youngest son Sailesh Mehta, who is chairman & managing director of the company.  

The Company is headquartered in Pune.

Insurance Industry - Indian Perspective - Thread 🧵

Growth Drivers :

Increasing Life Expectancy
Favorable Savings
Greater employment

@Atulsingh_asan @caniravkaria  @Coolfundoo @saketreddy @Jitendra_stock

#HDFCLIFE The growing interest in insurance among people, innovative products, and distribution channels are aiding growth.

High Penetration for digital platforms, with an average of 90% using digital platforms at least once a week

HDFCLIFE - 49% share of digital new business in FY20.

ITC FMCG - Segment Update.

Segment Revenue - 14728 cr

Growth - 14.7%

120+ innovative products launched – hygiene, health & wellness, naturals, convenience

Segment EBITDA up 44% in FY21

@dmuthuk ITC e-commerce FMCG Sales doubled: now accounts for ~5% of revenue

Increasing digital adoption by Traditional Trade & Collaboration with Online-delivery platforms

Rural markets continue to grow ahead of Urban/Metro

#IEX Thread⚡️

IEX - First and Largest Energy exchange in India (98% Market Share - Monopoly!!)

Automated trading platform for physical delivery of electricity, renewable power, energy certificates.

@Atulsingh_asan @caniravkaria @Coolfundoo @saketreddy @Jitendra_stock #IEX (2/n)

ROCE 5Yr - 63.9 %; ROE 5Yr - 45.0%

Zero Debt, Consistent FCF Generation

FII Holding - 5% in 2017 to 30% in 2020

Electricity CAGR 32% [CERC]

Revenue Breakup : 80% - Transaction Charges; 6% - Annual Subscription

Customer Base: 4000+ Industries

@vetris_stocks

#CDSL Thread 💰

India’s only listed and largest(no. of accounts) securities depository

Current BO Accounts: 2.89 Cr

BO accounts grew at a CAGR of 19% from 1.08 cr in FY 2015-16 to 2.12 cr in FY 2019-20

@Atulsingh_asan @caniravkaria @Coolfundoo @saketreddy @Jitendra_stock #CDSL (2/n)

ROCE 5Yr -22.7 %; ROE 5Yr -17.0 %

CDSL market share of investor accounts stands at 54% in FY20

CDSL incremental market share stands at 78% for FY20

Works similar to a bank but holds stocks and securities, not money

@vetris_stocks @ThetaVegaCap

#SequentScientific Thread. 🐂

ROCE 5Yr-13.6 %; ROE 5Yr-14.7 %; D/E-0.5
NO. 1 Animal health company from India
27 Commercial APIs
US$100MN+R&D investments
Promoter: Carlyle Group - 53%
Cons. Revenue UP 13% YOY

@unseenvalue @arc1471 @drprashantmish6 @MunkThePunk @caniravkaria #Sequent (2/n)
₹1,272 MN Cashflow from operations in FY20

100+ Countries Presence

Revenue: 66% from the formulations and the rest from APIs

SSL’s consolidated EBITDA margins improved to 14.4% in FY20 (FY19: 12.0%, FY18: 9.8%)

@Jitendra_stock @Investor_Mohit @ThetaVegaCap

The budget outlay for health is Rs 2,23,846 crore, an increase of 137% from last year's budget.[94,000 cr.]

PM Aatmanirbhar Swastha Bharat scheme with an outlay of Rs 64,180 crore.

@ShamikaRavi #Budget2021 #Health -4 National Institutes of Virology to be set up. At present, there is only one at Pune.

-Critical healthcare facilities to be set up in 62 districts.

-Mission Poshan 2.0 to be launched

#AatmanirbharBharatKaBudget #Budget2021

#UPL #Basics
-5th largest agrochem. company in the world (Mark. Cap: 34,699 Cr.)
-ROCE: 10.36 %
-ROE: 14.87 %
-D/E: 1.52
-Trading at a discounted price based on both P/S ratio (0.97) and Trailing P/E

@saketreddy @unseenvalue @caniravkaria @nid_rockz @ThetaVegaCap @DhanValue -Profit growth 5Years: 12.18
-MF increased their holding last month
-Wider footprint and extensive product portfolio to drive growth
-Arysta merger synergies to improve margins
-Long term revenue based on the company’s robust R&D initiatives on several new products
#Macquarie